Member Info for B2HS2L

The AACC at Atlanta was open from 28 -30 September. Only on the 30th did we get an R&D update with details of new and upgraded products.

How do you think Kevin Crittenton and Liz Ferreira (who was also present as per Larry response on twitter) felt, -
an opportunity missed?

OK I'm prepared to accept they knew about the contents of the 30th RNS before, but it was announced too late to encourage more interested parties attend the Novacyt AACC stand.

100% certain that David Allmond would not make such a schoolboy error.
Novacyt got no where near as much bang for their AACC buck due to someone taking their eye off the ball.

to clarify:
Option 2 gives the Novacyt Escapeplex test a Unique Selling Point, saving time and money for labs who purchase it.

Escapeplex image:
https://twitter.com/Blad3sharp/status/1443521414657716226/photo/2

Samples arrive at a sequencing lab, because they have previously tested positive.
Without Escapeplex's 2 gene test, and with no indication of the presence of Beta, Gamma, Delta or Delta plus:
1 - The sequencing lab received a negative sample labelled positive.
2 - The sequencing lab received a positive sample that does not have any of the above mutations, requiring further analysis.

Option 1 might be common. Time and retesting sample for a positive result would be necessary to verify.
link image states use as a reflex test, (use as a second test after a previous positive test).

Option 1 above gives the Novacyt Escapplex test a Unique Selling Point, saving time and money for labs who purchase it.

Escapeplex has to be competitive on price with competition products, so I assume after the introduction of a 2 gene test, it is still competitive.

Perhaps this implies the algo bots have been taken off the price, - but then I would expect an uptrend.

So why no rise then k?
Looking to buy but not willing to pull the trigger until plateau over (in a good way).

https://twitter.com/NovacytGroup/status/1443590969966825480

Free samples available...!

Easy12
IMO without the dispute, that is what GM intended to do, and that's what we would be doing now.
That was the plan as I see it.

Maverick12
Like your post but
...we only have ourselves to blame WHEN we got our entry levels wrong

Davand -

My Handle B2HS2L = Bought Too High Sold Too Low.

OK so I might have bought too high so far, but no plans to sell too low.

Hillseeker,

The following is an email exchange between myself and Attogene (US distributor) in mid-May this year, pertinent to your post.

B2HS2L:
Hi Attogene,

Your website offers the Primerdesign SNPsig® VariPLEX™ (Covid-19) Real-Time PCR Assay under the Research Use Only part number, - R00137.

I'm aware of the CE-IVD approved product part number D00060.

Could you provide an estimate when you will be offering the assay licensed for diagnostic procedures in US please?

+++++

Attogene response:

Hi B2HS2L,
We are unable to comment on FDA applications. However, this kit is being used in a similar fashion as other kits in clinical settings for detecting variants from diagnosed samples. There are no tests approved by the FDA for diagnosing variants to my knowledge.

Regards

Attogene Corp
3913 Todd Lane Suite 310
Austin TX 78744
512-333-1330

+++++

So RUO status is not a barrier to US sales anyway.

Thanks for your assistance EXMEX, I have the file open.
Some of the IT-IS staff have worked for Labman, and I have long suspected Labman are IT-IS subcontractors for a number of developments. They are my candidate manufacturer of Co-Prep.

Perhaps one question for the AGM on the 18th:

Are any of the products in our catalogue unavailable, or available in small quantities only, due to lack of manufacturing materials?

I suspect we know therefore what the sales team at AACC in Atlanta are concentrating on this week.
Significant interest indeed, - forward orders incoming me thinks, - and expecting a boost in q32 instrument sales:

"CO-Prep™ offers laboratories increased capacity, automation of repetitive manual pipetting, increased accuracy, reduction in intra-sample contamination risk, and time for technicians to concentrate on other work."

FORM AN ORDERLY QUEUE HERE PLEASE.

"The new CO-Prep™ instrument has received significant interest from customers in advance
of the launch next month. PROmate™ and Co-Prep™ have currently been designed for
testing of COVID-19, but both testing and instrument technologies can be used to target
additional diseases in the future."

I suspect we know therefore what the sales at AACC in Atlanta are concentrating on this week.
Significant interest indeed, - forward orders incoming me thinks.

EXMEX,
I don't have a copy of the new contract, - where can I find one please.

"Can't the AGM wait a few days"

Actually, - this possibly signals that the new CEO is already working in Southampton, and can be relied upon to be fully briefed come the 18th October.

Everbody,
This stock (Exsig direct and Winterplex) has a shelf life.
6 months after it has been manufactured, it is worthless.
If it is left in DHSC / NHS cold storage for months, it doesn't have the same value it had on delivery, when attempts are made to return it to manufacturer. It does not surprise me that NCYT are confident their legal position is sound in this dispute.

So what kind of Chairman allows (engineers?) a situation to occur that a new (brand new as it happens) CEO is caused to oversee / lead a rescheduled AGM on his first day because the first was not quorate?

How much respect does that show for the new guy by the Chairman?

What's the hurry, - get the resolutions through before the CEO wakes up to the full importance of them?

Can't the AGM wait a few days?

Does this show the new CEO is going to be the Chairman's Pimp?

I James Wakefield am now running this show?

Disrespectful to DA and SH in my view.

Companies (and long term shareholders) like to ensure that their CEO's are correctly motivated (recompensed) to do their job and ensure the company returns more profit this year than last. - Year after year. So the company becomes more and more profitable.

This year, because of the terms of the LTIP, the CEO and the ex-CFO become very very wealthy via bonuses.

So it can be argued Graham Mullis & Anthony Dyer can now no longer be considered correctly recompensed to ensure full motivation, (and GM may have wanted to retire this year anyway).
Anthony Dyer, - same goes for him, - unsure of his view on retirement.

They are now so rich the BoD feel there is a real risk they will sleepwalk when there is still a lot of work to do.

Action taken:
So on the 5th January 2021 Dyer becomes Chief Corporate Development Officer, seeking out suitable mergers, - except it's soon clear there isn't the cash available to engineer a merger due to dispute arising with No1 customer around February.
Dyer resigns from a lot of company positions on/after 5th January, replaced in most cases by the new CFO James McCarthy.

So that's Dyer dealt with.

The size of GM's bonus is very embarrassing for the board, and the first we hear is that GM is retiring.

He is kept in position for the time it takes to head hunt David Allmond, then GM's retirement is announced.

We keep having to join the dots.

This is my thoughts on Graham and Tony losing their positions.

Were they pushed, - not many options here unless GM did want to retire this year.

It's possible the board expected the AGM resolutions to attract insufficient votes, such that the AGM was not quorate.

Their pre-planned response is to get the same resolutions voted on, at the earliest possible date that DA was in charge, (and thus GM gone).

PI's tend to put shares that have lost a lot of value 'in the bottom draw', - and reduce their regular monitoring of the company. - Fine, but when an AGM needs to be quorate, those same investors are less inclined to vote, - resulting in difficulties with AGM's being quorate.

So NCYT PI's are under water big time, - plenty of share certificates in the bottom draw, - and hey presto, insufficient votes for an AGM. II's don't count, there are so few and no big holders.

Look how much effort the company put in last year, - nearly giving Mandy a nervous breakdown, - reminding SH's of the need to vote.

I don't recall the same activity levels encouraging PI voting by the company this year.

As I already said, the resolutions haven't changed at all.